Capstone Therapeutics Corp. announced by press release that it will host a teleconference and webcast to discuss AZX100 clinical and other data, on Tuesday, December 14, 2010 at 11:00am EST / 10:00am CST / 9:00am MST / 8:00am PST. The teleconference may be accessed at (877) 303-9204 (U.S.), (760) 536-5225 (outside U.S.); accompanying slides can be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning December 14, 2010 at 1:00pm EST until midnight December 17, 2010 and may be accessed at (800) 642-1687 (U.S.) or (706) 645-9291 (outside U.S.) with conference ID 30689632.
Tuesday, December 14, 2010
Capstone Therapeutics (Nasdaq:CAPS): -52% Call Can't Be Good
Capstone Therapeutics Corp. announced by press release that it will host a teleconference and webcast to discuss AZX100 clinical and other data, on Tuesday, December 14, 2010 at 11:00am EST / 10:00am CST / 9:00am MST / 8:00am PST. The teleconference may be accessed at (877) 303-9204 (U.S.), (760) 536-5225 (outside U.S.); accompanying slides can be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com. A replay will be available beginning December 14, 2010 at 1:00pm EST until midnight December 17, 2010 and may be accessed at (800) 642-1687 (U.S.) or (706) 645-9291 (outside U.S.) with conference ID 30689632.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment